A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 182
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MA
Long Form : megestrol acetate
No. Year Title Co-occurring Abbreviation
2019 Ten years of Croatian national guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome - Evaluation of awareness and implementation among Croatian oncologists. CC, EPA
2019 The effects of megestrol acetate on nutrition, inflammation and quality of life in elderly haemodialysis patients. ---
2018 Clinical Inquiry: Is megestrol acetate safe and effective for malnourished nursing home residents? RCT, SOR
2018 Enhanced antitumor activity of combined megestrol acetate and arsenic trioxide treatment in liver cancer cells. ATO
2018 Megestrol acetate for cachexia-anorexia syndrome. A systematic review. QOL
2018 Megestrol Acetate-Induced Symptomatic Hypogonadism in a Male Patient. AI, HPA, HPG
2018 Metabolism of megestrol acetate in vitro and the role of oxidative metabolites. HLMs, MS, NADPH, NMR, UGTs
2018 Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers. ---
2018 The management strategies of cancer-associated anorexia: a critical appraisal of systematic reviews. CACS, QOL, R-AMSTAR, SRs
10  2017 Effects of oral megestrol acetate administration on the hypothalamic-pituitary-adrenal axis of male bottlenose dolphins (Tursiops truncatus). ---
11  2017 Progesterone analogues reduce plasma Epstein-Barr virus DNA load and improve pain control in recurrent/metastatic nasopharyngeal carcinoma patients under supportive care. EBV, NPC
12  2016 Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation. HR
13  2016 The Efficacy and Safety of Megestrol Acetate in Protein-Energy Wasting due to Chronic Kidney Disease: A Systematic Review. AEs, CKD
14  2016 Using megestrol acetate to ameliorate protein-energy wasting in chronic kidney disease. CKD, PEW
15  2015 A combined spectroscopic and molecular docking approach to characterize binding interaction of megestrol acetate with bovine serum albumin. BSA
16  2015 Fertility-conservation combined therapy with hysteroscopic resection and oral progesterone for local early stage endometrial carcinoma in young women. ---
17  2015 Megace Mystery: A Case of Central Adrenal Insufficiency. HPA
18  2015 Megestrol Acetate Increases the Proliferation, Migration, and Adipogenic Differentiation of Adipose-Derived Stem Cells via Glucocorticoid Receptor. ASCs, GR, si
19  2015 Progestins to control feline reproduction: Historical abuse of high doses and potentially safe use of low doses. MPA, TNR
20  2014 A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy. ---
21  2014 Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial. CBR, CI, NSAI, PFS
22  2014 Can megestrol acetate induce thrombosis in advanced oncology patients receiving chemotherapy? OS
23  2014 Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia. CR, EAH, MS
24  2013 A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women. AH, EC
25  2013 Clinical evaluation and optimal management of cancer cachexia. CACS
26  2013 Comparison of three different treatment modalities in the management of cancer cachexia. EPA
27  2013 Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). BMI, CI, CR, MPA, OR
28  2013 Low-dose megestrol acetate revisited: a viable adjunct to surgical sterilization in free roaming cats? ---
29  2013 Megestrol acetate for treatment of anorexia-cachexia syndrome. AIDS
30  2013 Megestrol acetate may stimulate the production of insulin-like growth factor 1 in breast tissues of women with breast cancer. ER, PR, SHBG
31  2013 Primary symptomatic adrenal insufficiency induced by megestrol acetate. HPA
32  2013 Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects. HCC, MPA
33  2013 Safety of megestrol acetate in palliating anorexia-cachexia syndrome in patients with castration-resistant prostate cancer. CRPC, DSS
34  2013 Sterol regulatory element-binding protein-1/fatty acid synthase involvement in proliferation inhibition and apoptosis promotion induced by progesterone in endometrial cancer. EC
35  2012 A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life. CRP, GPS, IL, LBM, QOL, REE, ROS, TNF
36  2012 Altered claudin-4 expression in progesterone-treated endometrial adenocarcinoma cell line Ishikawa. ---
37  2012 AZA Wildlife Contraception Center programme for wild felids and canids. MGA, WCC
38  2012 Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide. CACS
39  2012 Pharmacological interventions for geriatric cachexia: a narrative review of the literature. ---
40  2012 [Regulation of claudin-4 gene expression in endometrial adenocarcinoma Ishikawa cell line by progesterone]. MTT
41  2011 Conservative management of young patients with endometrial highly-differentiated adenocarcinoma. MPA
42  2011 Conservative treatment of early endometrial cancer: preliminary results of a pilot study. EC, HSC, LNG-IUD
43  2011 Nanonization of megestrol acetate by laser fragmentation in aqueous milieu. fs, ns
44  2011 Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma. ECOG, HCC, HR, OS
45  2011 Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability. ---
46  2011 [Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss]. BMI, COPD
47  2010 Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature. LNG-IUS
48  2010 Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives. ---
49  2010 Megestrol acetate improves weight gain in pediatric patients with chronic kidney disease. CKD
50  2010 Megestrol acetate: its impact on muscle protein metabolism supports its use in cancer cachexia. ---
51  2010 Report of a pilot, double-blind, placebo-controlled study of megestrol acetate in elderly dialysis patients with cachexia. RPE
52  2010 Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. CRA, OLN, QOL
53  2009 Effect of megestrol acetate on serum albumin level in malnourished dialysis patients. ---
54  2009 Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly. O.S
55  2009 [Study on simultaneous determination method for banded synthesis hormones residues in egg products]. CDA, LOD, LOQ, MPA, MRM, MTS, NG, TSP
56  2008 Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds. EX, MAL, SA
57  2008 Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis. ACS, NNT
58  2008 Megestrol acetate-associated adrenal insufficiency. ---
59  2008 Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. ---
60  2008 The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia. CH
61  2007 A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight loss. ---
62  2007 Appetite stimulants in cystic fibrosis: a systematic review. CF
63  2007 Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer. ---
64  2007 Effects of muscle strength training and megestrol acetate on strength, muscle mass, and function in frail older people. PRMST
65  2007 Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. LBM
66  2007 [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome]. EPA
67  2006 High prevalence of adrenal suppression during acute illness in hospitalized patients receiving megestrol acetate. ---
68  2006 Megestrol acetate in cachexia and anorexia. ---
69  2006 Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions. CA, GF
70  2006 [Progesterone-modulated proteins in human endometrial cancer cell line Ishikawa]. COMT, MALDI-TOF MS, PMF
71  2005 Effects of megestrol acetate on pituitary function and end-organ hormone secretion: a post hoc analysis of serum samples from a 12-week study in healthy older men. ACTH, FSH, LH, PRL, RT, TSH
72  2005 Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis. CF, CH
73  2005 Megestrol acetate for the treatment of anorexia-cachexia syndrome. QOL
74  2005 Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men. FFM, ND
75  2004 An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. EPA
76  2004 Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. CR, PFS
77  2004 Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate. ---
78  2004 Progestins and place preference conditioning after paced mating. ---
79  2004 Risk factors relating blood markers of inflammation and nutritional status to survival in cachectic geriatric patients in a randomized clinical trial. IL, TNFR
80  2004 Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. ACS
81  2004 Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids. ---
82  2004 Treatment of anorexia and malnutrition in peritoneal dialysis patients with megestrol acetate. PD
83  2003 A review of the efficacy of anastrozole in postmenopausal women with advanced breast cancer with visceral metastases. ABC, AI, CB, HR
84  2003 Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate. BAP, EXE, IGF
85  2003 Effects of testosterone replacement and/or resistance training on interleukin-6, tumor necrosis factor alpha, and leptin in elderly men ingesting megestrol acetate: a randomized controlled trial. IL-6, TNF
86  2003 Mechanism of transient adrenal insufficiency with megestrol acetate treatment of cachexia in children with cancer. ---
87  2003 Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression. ---
88  2003 Megestrol acetate-induced weight gain does not negatively affect blood lipids in elderly men: effects of resistance training and testosterone replacement. HDL
89  2003 Palliative treatment of cancer anorexia with oral suspension of megestrol acetate. VAS
90  2002 A low-dose adrenocorticotropin test reveals impaired adrenal function in cancer patients receiving megestrol acetate therapy. ---
91  2002 Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. CI, FDA, RR, TTP
92  2002 Determination of acetyl gestagenic steroids in kidney fat by automated supercritical fluid extraction and liquid chromatography ion-trap mass spectrometry. CMA, LC-MSn, MGA, MPA, SFE
93  2002 Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: a randomized controlled trial. RT
94  2002 Megestrol acetate increases short-term food intake in zinc-deficient rats. NPY
95  2002 Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. ---
96  2002 Megestrol acetate to correct the nutritional status in an adolescent with growth hormone deficiency: Increase of appetite and body weight but only by increase of body water and fat mass followed by profound cortisol and testosterone depletion. GH
97  2002 Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy. QOL
98  2002 Treatment with megestrol acetate improves human immunodeficiency virus-associated immune thrombocytopenia. HIV, IgG
99  2001 A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss. FFM, FM, ND
100  2001 A summary of second-line randomized studies of aromatase inhibitors. ---